文献速递脑血管病外科神经重症

动脉瘤性蛛网膜下腔出血后血清钠水平波动的意义:一项探索性分析

Significance of fluctuations in serum sodium levels following aneurysmal subarachnoid hemorrhage: an exploratory analysis.
PubMed 文献 · J Neurosurg · 2018-08-17

该研究对CONSCIOUS-1试验数据做事后分析,每日记录动脉瘤性蛛网膜下腔出血患者14天内的血清钠值,基于入院钠、正常钠(140 mmol/L)及前一日钠三个参照点计算平均及平均绝对日差值。逐步logistic回归显示多个钠波动指标是3个月不良结局(mRS>2)的显著预测因子,而血管痉挛窗内波动对迟发性脑缺血仅呈接近显著趋势(p=0.052)。

要点

  • 基于入院钠、正常钠(140 mmol/L)及前一日钠计算的多个日差值指标是3个月不良结局(mRS>2)的显著预测因子。
  • 血管痉挛窗(第3-12天)内基于入院钠的平均绝对日差值预测迟发性脑缺血仅呈接近显著趋势(p=0.052)。
  • 第1-14天与血管痉挛窗(第3-12天)的钠波动对迟发性脑缺血的预测能力无差异。

核心结论

  • 血清钠水平波动可能在动脉瘤性蛛网膜下腔出血后的临床结局和迟发性脑缺血发生中起作用。
  • 这些波动的时间窗对迟发性脑缺血的发生似乎无显著影响。

研究设计与样本

  • 对CONSCIOUS-1试验数据的事后分析。
  • 患者动脉瘤性蛛网膜下腔出血后14天内每日记录血清钠值。
  • 基于入院钠水平、正常钠水平(定义为140 mmol/L)及前一日钠水平三个参照点,计算每例患者的平均日差值及平均绝对日差值。
  • 上述变量亦在动脉瘤性蛛网膜下腔出血后经典血管痉挛窗(第3-12天)内计算。
  • 采用逐步logistic回归模型、局部加权散点平滑曲线及受试者工作特征曲线分析评估钠水平变化与临床结局或迟发性脑缺血的关系。

主要发现

  • 在逐步多变量回归模型中,基于基线钠值的平均日差值(p<0.001)、基于正常钠水平的平均日差值(p<0.001)、基于正常钠水平的平均绝对日差值(p=0.015)及基于前一日钠水平的平均绝对日差值(p=0.017)均为不良结局的显著预测因子。
  • 血管痉挛窗内基于入院钠水平的平均绝对日差值作为迟发性脑缺血的独立预测因子呈接近显著趋势(p=0.052)。
  • 比较动脉瘤性蛛网膜下腔出血后第1-14天与经典血管痉挛窗(第3-12天)的钠波动,对迟发性脑缺血的预测能力无差异。

关键数值与推荐

  • 正常钠水平定义为140 mmol/L。
  • 不良结局定义为3个月时mRS评分>2。
  • 经典血管痉挛窗定义为动脉瘤性蛛网膜下腔出血后第3-12天。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Fluctuations in patient serum sodium levels are common after aneurysmal subarachnoid hemorrhage (aSAH), but their effect on patient outcome is not well described in the literature. The goal of this work was to better characterize the relationship between fluctuations in serum sodium levels, outcome, and the development of delayed cerebral ischemia (DCI) after aSAH. METHODS: The authors performed a post hoc analysis of data from the Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1) trial. Patients had their serum sodium values recorded daily for 14 days post-aSAH. Average and average absolute daily differences in sodium levels were calculated for each patient based on 3 reference points: admission sodium levels, a normal sodium level (defined as 140 mmol/L), and the previous day's sodium level. These variables were also calculated for the classic "vasospasm window" (days 3-12) post-aSAH. A stepwise logistic regression model, locally weighted scatterplot smoothing curves, and receiver operator characteristic curve analysis were used to evaluate the relationship between alterations in serum sodium levels and clinical outcome or the development of DCI after aSAH. Poor outcome was defined as a modified Rankin Scale (mRS) score of > 2 at 3 months. RESULTS: The average daily difference in sodium values from baseline (p < 0.001), average daily difference from a normal sodium level (p < 0.001), average absolute daily difference from a normal sodium level (p = 0.015), and average absolute daily difference from the previous day's sodium level (p = 0.017) were significant predictors of poor outcome in a stepwise multivariate regression model. There was a trend toward significance for average absolute daily difference from admission sodium levels during the vasospasm window as an independent predictor of DCI (p = 0.052). There was no difference in the predictive capacity for DCI when sodium fluctuations from post-aSAH days 1-14 were compared with those from the classic vasospasm window (days 3-12). CONCLUSIONS: Fluctuations in serum sodium levels may play a role in clinical outcome and the development of DCI after aSAH. The timing of these fluctuations appears to have no significant effect on the development of DCI.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Eagles ME, Tso MK, Macdonald RL, et al. Significance of fluctuations in serum sodium levels following aneurysmal subarachnoid hemorrhage: an exploratory analysis. J Neurosurg. 2018. PMID: 30117765. doi:10.3171/2018.3.JNS173068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。